6. Jha S, Topol EJ. Adapting to Artificial Intelligence: Radiologists and Pathologists as Information Specialists. JAMA. 2016; 316(22):2353–2354.
7. Darcy AM, Louie AK, Roberts LW. Machine Learning and the Profession of Medicine. JAMA. 2016; 315(6):551–552.
Article
8. Miotto R, Li L, Kidd BA, Dudley JT. Deep Patient: An Unsupervised Representation to Predict the Future of Patients from the Electronic Health Records. Sci Rep. 2016; 6:26094.
Article
9. Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RK, et al. The human splicing code reveals new insights into the genetic determinants of disease. Science. 2014; 347(6218):1254806.
Article
11. Nguyen P, Tran T, Wickramasinghe N, Venkatesh S. Deepr: A Convolutional Net for Medical Records. IEEE J Biomed Health Inform. 2017; 21(1):22–30.
23. Steps in developing Watson for Oncology, a decision support system to assist physicians choosing first-line metastatic breast cancer (MBC) therapies: Improved performance with machine learning. [Internet]. ASCO;2015. cited 2017 July 20. Available from:
http://meetinglibrary.asco.org/record/113826/abstract.
24. Integration of multi-modality treatment planning for early stage breast cancer (BC) into Watson for Oncology, a Decision Support System: Seeing the forest and the trees. [Internet]. ASCO;2015. cited 2017 July 20. Available from:
http://meetinglibrary.asco.org/record/112747/abstract.
29. Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol. 2003; 21(12):2237–2246.
Article